Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Colorectal cancer (CRC) is one of the most common malignancies worldwide. Approximately 10%–15% of the CRC cases have defective DNA mismatch repair (MMR) genes. Although the high level of microsatellite instability status is a predictor of favorable outcome in primary CRC, little is known about its frequency and importance in secondary CRC. Immunohistochemical staining (IHC) for MMR proteins (e.g., MLH1, MSH2, MSH6, and PMS2) has emerged as a useful technique to complement polymerase chain reaction (PCR) analyses. Methods: In this study, comparison between the MMR system of primary CRCs and paired liver and lung metastatic lesions was done using IHC and the correlation with clinical outcomes was also examined. Results: Based on IHC, 7/61 primary tumors (11.4%) showed deficient MMR systems, while 13/61 secondary tumors (21.3%) showed deficiencies. In total, 44 cases showed proficient expression in both the primary and metastatic lesions. Three cases showed deficiencies in both the primary and paired metastatic lesions. In 10 cases, proficient expression was found only in the primary lesions, and not in the corresponding metastatic lesions. In four cases, proficient expression was detected in the secondary tumor, but not in the primary tumor. Conclusions: Although each IHC result and the likely defective genes were not exactly matched between the primary and the metastatic tumors, identical results for primary and metastatic lesions were obtained in 77% of the cases (47/61). These data are in agreement with the previous microsatellite detection studies that used PCR and IHC.
Abstract
Background: Colorectal cancer (CRC) is one of the most common malignancies worldwide. Approximately 10%–15% of the CRC cases have defective DNA mismatch repair (MMR) genes. Although the high level of microsatellite instability status is a predictor of favorable outcome in primary CRC, little is known about its frequency and importance in secondary CRC. Immunohistochemical staining (IHC) for MMR proteins (e.g., MLH1, MSH2, MSH6, and PMS2) has emerged as a useful technique to complement polymerase chain reaction (PCR) analyses. Methods: In this study, comparison between the MMR system of primary CRCs and paired liver and lung metastatic lesions was done using IHC and the correlation with clinical outcomes was also examined. Results: Based on IHC, 7/61 primary tumors (11.4%) showed deficient MMR systems, while 13/61 secondary tumors (21.3%) showed deficiencies. In total, 44 cases showed proficient expression in both the primary and metastatic lesions. Three cases showed deficiencies in both the primary and paired metastatic lesions. In 10 cases, proficient expression was found only in the primary lesions, and not in the corresponding metastatic lesions. In four cases, proficient expression was detected in the secondary tumor, but not in the primary tumor. Conclusions: Although each IHC result and the likely defective genes were not exactly matched between the primary and the metastatic tumors, identical results for primary and metastatic lesions were obtained in 77% of the cases (47/61). These data are in agreement with the previous microsatellite detection studies that used PCR and IHC.
참고문헌 (20)
- Kanthan R, "Molecular events in primary and metastatic colorectal carcinoma : a review", Patholog Res Int, 2012, pp.597497~ (2012)
- Yim KL, "Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome", Med Oncol, 29, pp.1796~1801 (2012)
- Aaltonen LA, "Clues to the pathogenesis of familial colorectal cancer", Science, 260, pp.812~816 (1993)
- Geiersbach KB, "Microsatellite instability and colorectal cancer", Arch Pathol Lab Med, 135, pp.1269~1277 (2011)
- Shia J, "Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma", Semin Diagn Pathol, 32, pp.352~361 (2015)
- Vilar E, "Microsatellite instability in colorectal cancer : the stable evidence", Nat Rev Clin Oncol, 7, pp.153~162 (2010)
- Chen S, "Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1 : a case study in Bayesian meta-analysis of diagnostic tests without a gold standard", Biostatistics, 6, pp.450~464 (2005)
- Shia J, "Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1", PMS2 deficiency, 2013, pp.26, 131~138
- Zhang L, "Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing", J Mol Diagn, 10, pp.301~307 (2008)
- Shia J, "Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms", Am J Surg Pathol, 29, pp.96~104 (2005)
- Poulogiannis G, "DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome", Histopathology, 56, pp.167~179 (2010)
- Leach FS, "Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues", Cancer Res, 56, pp.235~240 (1996)
- Thibodeau SN, "Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes", Cancer Res, 56, pp.4836~4840 (1996)
- Lindor NM, "Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors", J Clin Oncol, 20, pp.1043~1048 (2002)
- Shia J, "Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry", Fam Cancer, 12, pp.241~260 (2013)
- Haraldsdottir S, "Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis", Fam Cancer, 15, pp.253~260 (2016)
- Agoston EI, "Occurrence, intratumoral heterogeneity, prognostic and predictive potential of microsatellite instability following surgical resection of primary colorectal carcinomas and corresponding liver metastases", Orv Hetil, 156, pp.1460~1471 (2015)
- Haddad R, "Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases", Ann Surg Oncol, 11, pp.977~982 (2004)
- Koopman M, "Deficient mismatch repair system in patients with sporadic advanced colorectal cancer", Br J Cancer, 100, pp.266~273 (2009)
- Kim ST, "The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer", Med Oncol, 27, pp.1277~1285 (2010)